Pacientes con Gripe por Virus Influenza A (H1N1)pdm09 ingresados en UCI. Impacto de las Recomendaciones de la SEMICYUC

OBJECTIVES: To evaluate the impact of the recommendations of the SEMICYUC (2012) on severe influenza A. DESIGN: A prospective multicenter observational study was carried out. SETTING: ICU. PATIENTS: Patients infected with severe influenza A (H1N1) from the GETGAG/SEMICYUC registry. INTERVENTIONS: An...

Descripción completa

Detalles Bibliográficos
Autores: Marin Corral, Judith, Climent Company, María Cristina, Muñoz Bermudez, Rosana, Samper Echevarria, Maria, Dot Jordana, Irene, 1982-, Vilà Vilardell, Clara, Masclans Enviz, Joan Ramon, Rodríguez, Alejandro, Martín Loeches, Ignacio, Álvarez Lerma, Francisco, H1N1 GETGAG/SEMICYUC Study Group
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2018
País:España
Institución:Universitat Pompeu Fabra
Repositorio:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/36036
Acceso en línea:http://hdl.handle.net/10230/36036
http://dx.doi.org/10.1016/j.medin.2018.02.002
Access Level:acceso abierto
Palabra clave:Grip A (H1N1)
Critically illness
Enfermedad crítica
Infección por virus influenza A (H1N1)pdm09
Influenza A (H1N1)pdm09 virus infection
Intensive Care Unit
Manejo terapéutico
Mortalidad
Mortality
Outcome
Pronóstico
Therapeutic management
Unidad de Cuidados Intensivos
id ES_1debc3ec3e40c9fa920cee442c4e77bb
oai_identifier_str oai:repositori.upf.edu:10230/36036
network_acronym_str ES
network_name_str España
repository_id_str
spelling Pacientes con Gripe por Virus Influenza A (H1N1)pdm09 ingresados en UCI. Impacto de las Recomendaciones de la SEMICYUCMarin Corral, JudithCliment Company, María CristinaMuñoz Bermudez, RosanaSamper Echevarria, MariaDot Jordana, Irene, 1982-Vilà Vilardell, ClaraMasclans Enviz, Joan RamonRodríguez, AlejandroMartín Loeches, IgnacioÁlvarez Lerma, FranciscoH1N1 GETGAG/SEMICYUC Study GroupGrip A (H1N1)Critically illnessEnfermedad críticaInfección por virus influenza A (H1N1)pdm09Influenza A (H1N1)pdm09 virus infectionIntensive Care UnitManejo terapéuticoMortalidadMortalityOutcomePronósticoTherapeutic managementUnidad de Cuidados IntensivosOBJECTIVES: To evaluate the impact of the recommendations of the SEMICYUC (2012) on severe influenza A. DESIGN: A prospective multicenter observational study was carried out. SETTING: ICU. PATIENTS: Patients infected with severe influenza A (H1N1) from the GETGAG/SEMICYUC registry. INTERVENTIONS: Analysis of 2 groups according to the epidemic period of the diagnosis (2009-2011; 2013-2015). VARIABLES: Demographic, temporal, comorbidities, severity, treatments, mortality, late diagnosis and place of acquisition. RESULTS: A total of 2,205 patients were included, 1,337 (60.6%) in the first period and 868 (39.4%) in the second one. Age and severity on admission were significantly greater in the second period, as well as co-infection. With regard to the impact of the recommendations, in the second period the diagnosis was established earlier (70.8 vs. 61.1%, P<.001), without changes in the start of treatment. Patients received less corticosteroid treatment (39.7 vs. 44.9%, P<.05), more NIMV was used (47.4 vs. 33.2%, P<.001) and more vaccination was made (11.1 vs. 1.7%, P<.001), without changes in mortality (24.2 vs. 20.7%). A decrease in nosocomial infection was also noted (9.8 vs. 16%, P<.001). Patients needed less MV with more days of ventilation, more vasopressor drug use and more ventral decubitus. CONCLUSIONS: The management of patients with severe influenza A (H1N1) has changed over the years, though without changes in mortality. The recommendations of the SEMICYUC (2012) have allowed earlier diagnosis and improved corticosteroid use. Pending challenges are the delay in treatment, the vaccination rate and the use of NIMV.Elsevier20182018info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/36036http://dx.doi.org/10.1016/j.medin.2018.02.002reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraEspañolMedicina intensiva. 2018 Nov;42(8):473-81© Elsevier http://dx.doi.org/10.1016/j.medin.2018.02.002info:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/360362026-06-12T07:21:37Z
dc.title.none.fl_str_mv Pacientes con Gripe por Virus Influenza A (H1N1)pdm09 ingresados en UCI. Impacto de las Recomendaciones de la SEMICYUC
title Pacientes con Gripe por Virus Influenza A (H1N1)pdm09 ingresados en UCI. Impacto de las Recomendaciones de la SEMICYUC
spellingShingle Pacientes con Gripe por Virus Influenza A (H1N1)pdm09 ingresados en UCI. Impacto de las Recomendaciones de la SEMICYUC
Marin Corral, Judith
Grip A (H1N1)
Critically illness
Enfermedad crítica
Infección por virus influenza A (H1N1)pdm09
Influenza A (H1N1)pdm09 virus infection
Intensive Care Unit
Manejo terapéutico
Mortalidad
Mortality
Outcome
Pronóstico
Therapeutic management
Unidad de Cuidados Intensivos
title_short Pacientes con Gripe por Virus Influenza A (H1N1)pdm09 ingresados en UCI. Impacto de las Recomendaciones de la SEMICYUC
title_full Pacientes con Gripe por Virus Influenza A (H1N1)pdm09 ingresados en UCI. Impacto de las Recomendaciones de la SEMICYUC
title_fullStr Pacientes con Gripe por Virus Influenza A (H1N1)pdm09 ingresados en UCI. Impacto de las Recomendaciones de la SEMICYUC
title_full_unstemmed Pacientes con Gripe por Virus Influenza A (H1N1)pdm09 ingresados en UCI. Impacto de las Recomendaciones de la SEMICYUC
title_sort Pacientes con Gripe por Virus Influenza A (H1N1)pdm09 ingresados en UCI. Impacto de las Recomendaciones de la SEMICYUC
dc.creator.none.fl_str_mv Marin Corral, Judith
Climent Company, María Cristina
Muñoz Bermudez, Rosana
Samper Echevarria, Maria
Dot Jordana, Irene, 1982-
Vilà Vilardell, Clara
Masclans Enviz, Joan Ramon
Rodríguez, Alejandro
Martín Loeches, Ignacio
Álvarez Lerma, Francisco
H1N1 GETGAG/SEMICYUC Study Group
author Marin Corral, Judith
author_facet Marin Corral, Judith
Climent Company, María Cristina
Muñoz Bermudez, Rosana
Samper Echevarria, Maria
Dot Jordana, Irene, 1982-
Vilà Vilardell, Clara
Masclans Enviz, Joan Ramon
Rodríguez, Alejandro
Martín Loeches, Ignacio
Álvarez Lerma, Francisco
H1N1 GETGAG/SEMICYUC Study Group
author_role author
author2 Climent Company, María Cristina
Muñoz Bermudez, Rosana
Samper Echevarria, Maria
Dot Jordana, Irene, 1982-
Vilà Vilardell, Clara
Masclans Enviz, Joan Ramon
Rodríguez, Alejandro
Martín Loeches, Ignacio
Álvarez Lerma, Francisco
H1N1 GETGAG/SEMICYUC Study Group
author2_role author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Grip A (H1N1)
Critically illness
Enfermedad crítica
Infección por virus influenza A (H1N1)pdm09
Influenza A (H1N1)pdm09 virus infection
Intensive Care Unit
Manejo terapéutico
Mortalidad
Mortality
Outcome
Pronóstico
Therapeutic management
Unidad de Cuidados Intensivos
topic Grip A (H1N1)
Critically illness
Enfermedad crítica
Infección por virus influenza A (H1N1)pdm09
Influenza A (H1N1)pdm09 virus infection
Intensive Care Unit
Manejo terapéutico
Mortalidad
Mortality
Outcome
Pronóstico
Therapeutic management
Unidad de Cuidados Intensivos
description OBJECTIVES: To evaluate the impact of the recommendations of the SEMICYUC (2012) on severe influenza A. DESIGN: A prospective multicenter observational study was carried out. SETTING: ICU. PATIENTS: Patients infected with severe influenza A (H1N1) from the GETGAG/SEMICYUC registry. INTERVENTIONS: Analysis of 2 groups according to the epidemic period of the diagnosis (2009-2011; 2013-2015). VARIABLES: Demographic, temporal, comorbidities, severity, treatments, mortality, late diagnosis and place of acquisition. RESULTS: A total of 2,205 patients were included, 1,337 (60.6%) in the first period and 868 (39.4%) in the second one. Age and severity on admission were significantly greater in the second period, as well as co-infection. With regard to the impact of the recommendations, in the second period the diagnosis was established earlier (70.8 vs. 61.1%, P<.001), without changes in the start of treatment. Patients received less corticosteroid treatment (39.7 vs. 44.9%, P<.05), more NIMV was used (47.4 vs. 33.2%, P<.001) and more vaccination was made (11.1 vs. 1.7%, P<.001), without changes in mortality (24.2 vs. 20.7%). A decrease in nosocomial infection was also noted (9.8 vs. 16%, P<.001). Patients needed less MV with more days of ventilation, more vasopressor drug use and more ventral decubitus. CONCLUSIONS: The management of patients with severe influenza A (H1N1) has changed over the years, though without changes in mortality. The recommendations of the SEMICYUC (2012) have allowed earlier diagnosis and improved corticosteroid use. Pending challenges are the delay in treatment, the vaccination rate and the use of NIMV.
publishDate 2018
dc.date.none.fl_str_mv 2018
2018
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
format article
status_str acceptedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10230/36036
http://dx.doi.org/10.1016/j.medin.2018.02.002
url http://hdl.handle.net/10230/36036
http://dx.doi.org/10.1016/j.medin.2018.02.002
dc.language.none.fl_str_mv Español
language_invalid_str_mv Español
dc.relation.none.fl_str_mv Medicina intensiva. 2018 Nov;42(8):473-81
dc.rights.none.fl_str_mv © Elsevier http://dx.doi.org/10.1016/j.medin.2018.02.002
info:eu-repo/semantics/openAccess
rights_invalid_str_mv © Elsevier http://dx.doi.org/10.1016/j.medin.2018.02.002
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositorio Digital de la UPF
instname:Universitat Pompeu Fabra
instname_str Universitat Pompeu Fabra
reponame_str Repositorio Digital de la UPF
collection Repositorio Digital de la UPF
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869404307366871040
score 15,811543